Table 3.
Evaluation of biochemical parameters in the control group (CG) and intervention group (IG).
| CG (n = 15) | IG (n = 15) | |||||
|---|---|---|---|---|---|---|
| T0 | T1 | P | T0 | T1 | P | |
| Total Cholesterol * | 183.5 ± 32.6 | 173.0 ± 29.4 | 0.008 | 176.9 ± 35.8 | 149.7 ± 43.8 | 0.031 |
| Glucose * | 84.0 ± 9.2 | 83.7 ± 7.3 | 0.314 | 82.5 ± 5.2 | 80.1 ± 14.8 | 0.128 |
| Creatinine * | 0.8 ± 0.1 | 0.8 ± 0.1 | 0.275 | 0.8 ± 0.1 | 0.7 ± 0.1 | 0.014 |
| ALAT | 17.2 ± 10.0 | 15.3 ± 4.5 | 0.324 | 18.3 ± 8.7 | 16.2 ± 8.4 | 0.426 |
| ASAT | 21.7 ± 4.7 | 20.7 ± 2.8 | 0.239 | 20.6 ± 5.4 | 18.6 ± 5.8 | 0.091 |
Legend: CG—control group; IG—intervention group T0—first contact with the participants; T1—moment one month after the intervention; ALAT: alanine aminotransferase; ASAT: aspartate aminotransferase; P: p-value; * units of measurement—mg/dL; ALAT and ASAT—units of measurement U/L.